Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes (Q54472764)

30 May 2018

title

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes (English)

1 reference

14 August 2023

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147291

14 August 2023

1 reference

14 August 2023

author name string

K. P. Ratzmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147291

14 August 2023

B. Schulz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147291

14 August 2023

P. Heinke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147291

14 August 2023

W. Besch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147291

14 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6147291

14 August 2023

publication date

1 July 1984

1 reference

30 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00253493.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00253493/fulltext.html

14 August 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00253493

14 August 2023

1 reference

14 August 2023

1 reference

30 May 2018

volume

27

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

8-12

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00253493

exact match

0 references

cites work

Appraisal of the Extrapancreatic Actions of Sulfonylureas

1 reference

12 December 2020

[A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method]

1 reference

12 December 2020

The action of hypoglycaemic sulphonylureas on carbohydrate metabolism in the fasted rat

1 reference

12 December 2020

A Stimulatory Effect of Tolbutamide on the Insulin-Mediated Glucose Uptake in Subjects with Impaired Glucose Tolerance (IGT)

1 reference

12 December 2020

The effect of ageing on insulin sensitivity and insulin secretion in non-obese healthy subjects.

1 reference

12 December 2020

Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion.

1 reference

12 December 2020

Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood

1 reference

12 December 2020

Glucose metabolism in the basal state and during a two-hour glucose infusion in low insulin responders and control subjects

1 reference

12 December 2020

Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide

1 reference

12 December 2020

Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients

1 reference

12 December 2020

Effects of substituted sulfonylureas on rat diaphragm and liver tissue

1 reference

12 December 2020

An insulin dependent effect of chronic tolbutamide administration on the skeletal muscle carbohydrate transport system

1 reference

12 December 2020

Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics

1 reference

12 December 2020

Improved insulin receptor assay: effects of an antidiabetic sulphonylurea on liver membrane insulin receptors from obese hyperglycaemic mice

1 reference

12 December 2020

POTENTIATION OF INSULIN ACTION ON THE LIVER BY TOLBUTAMIDE

1 reference

12 December 2020

THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA

1 reference

12 December 2020

Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.

1 reference

12 December 2020

Waveform requirements for metabolic normalization with continuous intravenous insulin delivery in man

1 reference

12 December 2020

The insulin receptor in insulin-dependent diabetes mellitus: an in vivo and in vitro study

1 reference

12 December 2020

Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic Usefulness

1 reference

12 December 2020

Acute tolbutamide administration alone or combined with insulin enhances glucose uptake in the perfused rat hindlimb

1 reference

12 December 2020

LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective

1 reference

12 December 2020

Further support for heterogeneity of insulin response and insulin sensitivity in non-obese subjects with glucose intolerance

1 reference

12 December 2020

Potentiation of the Hepatic Action of Insulin by Chlorpropamide

1 reference

12 December 2020

Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide

1 reference

12 December 2020

Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells

1 reference

12 December 2020

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

1 reference

12 December 2020

Insulin resistance is a prominent feature of insulin-dependent diabetes

1 reference

12 December 2020

The mechanism of action of tolbutamide. Observations on the effects of sulfonylureas on peripheral metabolism in man

1 reference

12 December 2020

Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery.

1 reference

12 December 2020

Sulfonylurea treatment of insulin-independent diabetes mellitus

1 reference

12 December 2020

Regulation of pancreatic glucagon secretion during a continuous glucose infusion in early and overt diabetics

1 reference

12 December 2020

The Acute Effects of Tolbutamide on Forearm Metabolism

1 reference

12 December 2020

In vitro metabolic effects of gliclazide and glibenclamide in the rat

1 reference

12 December 2020

Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance

1 reference

12 December 2020

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

1 reference

12 December 2020

Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors

1 reference

12 December 2020

Improvement of Human Growth Hormone Immunoassay Using 125I

1 reference

12 December 2020

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics

1 reference

12 December 2020

Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00253493

1 reference

30 May 2018

1 reference

30 May 2018